We're developing SkinTE, which is revolutionizing the science for these hard-to-close wounds.

"The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of inflammation

A conversation with Dr. Nick West, chief medical officer at Abbott's vascular business.

An Empowered Patient Podcast at Medical and Pharma Insider hosted by Karen Jagoda Dr. Pier Vincenzo Piazza is Co-Founder and CEO of Aelis...

"So, we answer three fundamental questions for the patient, which is where should I go? How much is it going to cost? And when can I be seen

"Whether those metrics are tied to the admissions or length of stay ... most health systems are managing performance on Excel spreadsheets"

...while the brain is arguably more in our biology domain, we really have to understand brain health in a very integrative way..."

FT218 optimizes the release of sodium oxybate and with a proprietary controlled-release technology allows for a single bedtime dose.

In this Empowered Patient Podcast, Greg discusses the role of contact centers in personalizing inbound and outbound encounters with patients

Pierre Pellier, CEO of CTMA's, objective is to provide better access to innovative and potentially life-saving therapies to more patients.

Calliditas is focused on the rare kidney disease IgA nephropathy. While there is a genetic predisposition for this autoimmune disease...

Integrating Medisafe into patient engagement enables key data to be collected about adherence and potential obstacles to drug adherence.

Palisade is developing a breakthrough platform technology to measure the activity of digestive enzymes from the gastrointestinal tract.

HSBlox enables SDOH risk-stratification, care coordination and appropriate data sharing through its digital health platform.

Care Navigators benefit patients and doctors as they reduce paperwork and allows physicians to focus on transitioning to value-based care.

"Vicarious Surgical's novel uses a combination of miniaturized surgical robots and virtual reality to transport surgeons inside the body"

The challenge is how can healthcare stakeholders improve the delivery of Social Determinants of Health to better serve vulnerable people.

The key is stimulating a type of immune cell called invariant natural killer T-cell...

Addressing the social determinants of health SDOH is top of mind in the improvement of population health particularly in the age of COVID.

The PLUS lead investigational Rhenium NanoLiposome delivers radiation directly to the tumor using a proprietary method.